Immunogenicity 13731
Sample ID
3903
Response
Negative
Tumor Type
Melanoma
Gene Symbol
CASD1
Transcript ID
uc003unj.4
HLA INFO
A*24:02
TCR INFO
No TCR info found!
Full length protein sequence (797 aa)
MAALA
1
YNLGK
6
REINH
11
YFSVR
16
SAKVL
21
ALVAV
26
LLLAA
31
CHLAS
36
RRYRG
41
NDSCE
46
YLLSS
51
GRFLG
56
EKVWQ
61
PHSCM
66
MHKYK
71
ISEAK
76
NCLVD
81
KHIAF
86
IGDSR
91
IRQLF
96
YSFVK
101
IINPQ
106
FKEEG
111
NKHEN
116
IPFED
121
KTASV
126
KVDFL
131
WHPEV
136
NGSMK
141
QCIKV
146
WTEDS
151
IAKPH
156
VIVAG
161
AATWS
166
IKIHN
171
GSSEA
176
LSQYK
181
MNITS
186
IAPLL
191
EKLAK
196
TSDVY
201
WVLQD
206
PVYED
211
LLSEN
216
RKMIT
221
NEKID
226
AYNEA
231
AVSIL
236
NSSTR
241
NSKSN
246
VKMFS
251
VSKLI
256
AQETI
261
MESLD
266
GLHLP
271
ESSRE
276
TTAMI
281
LMNVY
286
CNKIL
291
KPVDG
296
SCCQP
301
RPPVT
306
LIQKL
311
AACFF
316
TLSII
321
GYLIF
326
YIIHR
331
NAHRK
336
NKPCT
341
DLESG
346
EEKKN
351
IINTP
356
VSSLE
361
ILLQS
366
FCKLG
371
LIMAY
376
FYMCD
381
RANLF
386
MKENK
391
FYTHS
396
SFFIP
401
IIYIL
406
VLGVF
411
YNENT
416
KETKV
421
LNREQ
426
TDEWK
431
GWMQL
436
VILIY
441
HISGA
446
STFLP
451
VYMHI
456
RVLVA
461
AYLFQ
466
TGYGH
471
FSYFW
476
IKGDF
481
GIYRV
486
CQVLF
491
RLNFL
496
VVVLC
501
IVMDR
506
PYQFY
511
YFVPL
516
VTVWF
521
MVIYV
526
TLALW
531
PQIIQ
536
KKANG
541
NCFWH
546
FGLLL
551
KLGFL
556
LLFIC
561
FLAYS
566
QGAFE
571
KIFSL
576
WPLSK
581
CFELK
586
GNVYE
591
WWFRW
596
RLDRY
601
VFFHG
606
MLFAF
611
IYLAL
616
QKRQI
621
LSEGK
626
GEPLF
631
SNKIS
636
NFLLF
641
ISVVS
646
FLTYS
651
IWASS
656
CKNKA
661
ECNEL
666
HPSVS
671
VVQIL
676
AFILI
681
RNIPG
686
YARSV
691
YSSFF
696
AWFGK
701
ISLEL
706
FICQY
711
HIWLA
716
ADTRG
721
ILVLI
726
PGNPM
731
LNIIV
736
STFIF
741
VCVAH
746
EISQI
751
TNDLA
756
QIIIP
761
KDNSS
766
LLKRL
771
ACIAA
776
FFCGL
781
LILSS
786
IQDKS
791
KH
796
Mutation Information
DNA mutation:
None
Peptide Range:
635 ~ 659
Mut AA position:
647 (13 in Wild Type peptide)
Alignment
Wild Type:
"FSNKISNFLLFISVVSFLTYSIWAS
||||||||||||.||||||||||||
Mutant:
FSNKISNFLLFILVVSFLTYSIWAS"
Nat Med, 2016
Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patientsGene Name (from Reference) CASD1
Checkpoint
Blockade
None
ACT
None
Vaccination
None
Curative
Effect
None
minimal_peptide
None
Antigen
Type
TMG RNA
T-cell
Source
PBMCs
APC
Type
autologous DCs
Assay
IFNg ELISPOT assay